Manulife (Manufacturers Life Insurance)’s Anthera Pharmaceuticals, Inc. ANTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-193
Closed 4438
2017
Q2
$0 Sell
193
-4
-2% -$9 ﹤0.01% 4524
2017
Q1
$1K Hold
197
﹤0.01% 4150
2016
Q4
$1K Sell
197
-1,467
-88% -$25.4K ﹤0.01% 4297
2016
Q3
$42K Buy
1,664
+1,467
+745% +$37K ﹤0.01% 3430
2016
Q2
$5K Sell
197
-3,302
-94% -$93.3K ﹤0.01% 3835
2016
Q1
$98K Buy
3,499
+391
+13% +$10.6K ﹤0.01% 3059
2015
Q4
$115 Hold
3,108
﹤0.01% 3029
2015
Q3
$151 Buy
3,108
+226
+8% +$15.8K ﹤0.01% 2886
2015
Q2
$199 Buy
2,882
+2,576
+842% +$119K ﹤0.01% 2852
2015
Q1
$11 Hold
306
﹤0.01% 3542
2014
Q4
$4 Hold
306
﹤0.01% 3666
2014
Q3
$5 Buy
306
+291
+1,940% +$6.12K ﹤0.01% 3643
2014
Q2
$0 Hold
15
﹤0.01% 3917
2014
Q1
$0 Hold
15
﹤0.01% 3870
2013
Q4
$0 Hold
15
﹤0.01% 3885
2013
Q3
$0 Buy
+15
New +$465 ﹤0.01% 3765

Other funds holding ANTH

Manulife (Manufacturers Life Insurance)'s ANTH Position: Q3 2017 in Review

Manulife (Manufacturers Life Insurance) sold out of Anthera Pharmaceuticals, Inc. (ANTH) in Q3 2017, closing a stake of 193 shares.

Manulife (Manufacturers Life Insurance) first reported a position in ANTH in Q3 2013 and held it in 16 quarters. The position peaked at $98K in Q1 2016. 35 funds tracked by Wall St. Rank hold ANTH as of Q3 2017.

  • Manulife (Manufacturers Life Insurance) reported no remaining Anthera Pharmaceuticals, Inc. position as of Q3 2017 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 193 Anthera Pharmaceuticals, Inc. shares in Q3 2017.
  • Manulife (Manufacturers Life Insurance) first reported a position in Anthera Pharmaceuticals, Inc. in Q3 2013 and held it in 16 quarters.
  • Manulife (Manufacturers Life Insurance)'s Anthera Pharmaceuticals, Inc. position peaked at $98K in Q1 2016.
  • 35 funds tracked by Wall St. Rank held Anthera Pharmaceuticals, Inc. as of Q3 2017.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q3 2017, filed 14 Nov 2017.